The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 25, 1995
Filed:
Feb. 17, 1993
Applicant:
Inventor:
Engelbert Ciganek, Kennett Square, PA (US);
Assignee:
The DuPont Merck Pharmaceutical Company, Wilmington, DE (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D / ; C07D / ; C07D / ; C07D / ; A61K / ; A61K / ; A61K / ; A61K / ;
U.S. Cl.
CPC ...
514248 ; 514255 ; 514256 ; 514259 ; 514300 ; 514307 ; 514314 ; 514339 ; 514414 ; 514415 ; 514416 ; 544237 ; 544242 ; 544333 ; 544335 ; 544336 ; 544405 ; 544410 ; 544283 ; 544284 ; 546122 ; 546139 ; 546148 ; 546149 ; 546152 ; 546180 ; 546181 ; 546272 ; 546273 ; 548454 ; 548455 ; 548469 ; 548470 ; 548482 ; 548515 ;
Abstract
There are provided novel nitrogen-containing bicyclic compounds which are useful in the treatment of physiological or drug induced psychosis or dyskinesia in a mammal. These novel compounds are selective sigma receptor antagonists and have a low potential for movement disorder side effects associated with typical antipsychotic agents.
Ciganek, Engelbert. (1995). Hydroisoindolines and hydroisoquinolines as psychotropic drugs (U.S. Patent No. 5409929). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/5409929
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile